Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 161 results found. Search for [ Indian drug makers ]

Results 1 to 21 of 161
PB Jayakumar
New Delhi, May 15, 2019
In 2018, India has the largest number of US regulator approved pharmaceutical plants outside the US.


PTI
New Delhi, May 15, 2019
These European companies are circumventing the FDA's safety requirements and placing the lives of women and their children at risk, the lawmakers said in a letter to Acting FDA Commissioner Norman Sharpless


PTI
May 14, 2019
In separate clarifications to stock exchanges, the companies denied the accusations and stated they would defend themselves in the matter


PTI
May 14, 2019



Mudit Kapoor
May 14, 2019
Severe penalties could be levied on the Indian pharma companies varying from $13 million to $873 million; Glenmark could face the highest penalty, while Aurobindo the least.


BusinessToday.In
New Delhi, May 14, 2019
The lawsuit accuses Teva Pharmaceuticals USA Inc of orchestrating a sweeping scheme with 19 other companies to inflate drug prices, by more than 1,000% in some cases


BusinessToday.In
May 14, 2019
Markets Live: While Sensex is trading 263 points higher at 37,354, Nifty is up 83 points to 11,231.70. Sun Pharma, Vedanta and ICICI Bank were the top gainers on Sensex. Tata Steel, Bajaj Auto and Asian Paints were the top losers on Sensex.


PTI
May 11, 2019



BusinessToday.In
May 9, 2019
In as many as 666 cases, pharma companies are yet to disgorge excess profits accrued by overcharging customers under the Drug Prices Control Orders. The DoP has now made a one-time settlement offer on their total outstanding dues, provided they collectively cough up Rs 3,501 crore and drop their lawsuits


Joe C Mathew
New Delhi, April 29, 2019
New think tank to build India's case in pharma, healthcare with the world


PTI
April 29, 2019



PTI
April 20, 2019



BusinessToday.In
April 5, 2019
Share Market updates: Sensex closes 177 points or 0.46% higher at 38,862 level, Nifty rises 67 points to 11,665 level.


PB Jayakumar
NA, March 18, 2019
Indian pharma companies need to move fast on THE digital highway to stay relevant in the future.


PB Jayakumar
February 22, 2019
An expert on IP rights and international trade relations related to pharmaceuticals, Shah had fought for Indian generic industry in several WTO and many other international pharma and IPR deliberations.


PTI
December 13, 2018



PB Jayakumar
New Delhi, November 28, 2018
The US Food and Drug Administration is coming out with clear guidelines for clearing complex generics.


PTI
November 27, 2018



PTI
October 28, 2018



PTI
October 9, 2018



PAGES 1 OF 9  12345